Dr. Thomas Wilckens
Thomas is a MD, serial entrepreneur. His current venture InnVentis focuses on the convergence of multi-omics technologies Big DATA/machine learning and real-world clinical data to enable PRECISION MEDICINE. Besides InnVentis, Thomas is an associate at deep innovation GmbH, a boutique incubator/consultancy headed by the fmr. Head Group R&D Vodafone with a focus on the creation of new, disruptive products and services from converging technologies. Before joining deep innovation, he headed a drug discovery company as CEO/CSO with a focus on inflammatory and metabolic diseases. Aside from his work in biomedicine he developed a novel concept for value creation in research intensive industries; i.e. Symbiotic Innovation. With regard to this project Thomas is an associate at the GLORAD Research Center for Global R&D Management St. Gallen/Shanghai.